"The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin "...
Yervoy Patient Information including How Should I Take
In this Article
- What is ipilimumab (Yervoy)?
- What are the possible side effects of ipilimumab (Yervoy)?
- What is the most important information I should know about ipilimumab (Yervoy)?
- What should I discuss with my healthcare provider before receiving ipilimumab (Yervoy)?
- How is ipilimumab given (Yervoy)?
- What happens if I miss a dose (Yervoy)?
- What happens if I overdose (Yervoy)?
- What should I avoid while receiving ipilimumab (Yervoy)?
- What other drugs will affect ipilimumab (Yervoy)?
- Where can I get more information?
What should I discuss with my healthcare provider before receiving ipilimumab (Yervoy)?
You should not receive ipilimumab if you are allergic to it.
To make sure you can safely receive ipilimumab, tell your doctor if you have any of these other conditions:
- liver damage (caused by disease or by using certain medicines);
- an autoimmune disorder such as systemic lupus erythematosus (SLE) or sarcoidosis;
- Crohn's disease or ulcerative colitis; or
- if you have received an organ transplant.
FDA pregnancy category C. It is not known whether ipilimumab will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.
In animal studies, ipilimumab caused stillbirth, premature delivery, low birth weight, miscarriage in the third trimester, and infant death. However, very high doses are used in animal studies. It is not known whether these effects would occur in people using doses recommended for human use. Ask your doctor about your individual risk.
It is not known whether ipilimumab passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are receiving ipilimumab.
How is ipilimumab given (Yervoy)?
Ipilimumab is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. Ipilimumab must be given slowly, and the IV infusion can take about 90 minutes to complete.
Ipilimumab is usually given every 3 weeks for up to 4 doses. Follow your doctor's instructions.
You may be given other medications to treat or prevent certain side effects of ipilimumab.
To make sure this medication is helping your condition and not causing harmful effects, your blood will need to be tested often. Your cancer treatments may be delayed based on the results of these tests. Do not miss any follow-up visits to your doctor.
Additional Yervoy Information
- Yervoy Drug Interactions Center: ipilimumab iv
- Yervoy Side Effects Center
- Yervoy Overview including Precautions
- Yervoy FDA Approved Prescribing Information including Dosage
Yervoy - User Reviews
Yervoy User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.